Viruses 2013, 5(5), 1250-1260; doi:10.3390/v5051250
Review

Suppression of Coronavirus Replication by Cyclophilin Inhibitors

1,* email, 2 and 3
Received: 18 March 2013; in revised form: 2 May 2013 / Accepted: 8 May 2013 / Published: 22 May 2013
(This article belongs to the Special Issue Cyclophilins and Viruses)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Coronaviruses infect a variety of mammalian and avian species and cause serious diseases in humans, cats, mice, and birds in the form of severe acute respiratory syndrome (SARS), feline infectious peritonitis (FIP), mouse hepatitis, and avian infectious bronchitis, respectively. No effective vaccine or treatment has been developed for SARS-coronavirus or FIP virus, both of which cause lethal diseases. It has been reported that a cyclophilin inhibitor, cyclosporin A (CsA), could inhibit the replication of coronaviruses. CsA is a well-known immunosuppressive drug that binds to cellular cyclophilins to inhibit calcineurin, a calcium-calmodulin-activated serine/threonine-specific phosphatase. The inhibition of calcineurin blocks the translocation of nuclear factor of activated T cells from the cytosol into the nucleus, thus preventing the transcription of genes encoding cytokines such as interleukin-2. Cyclophilins are peptidyl-prolyl isomerases with physiological functions that have been described for many years to include chaperone and foldase activities. Also, many viruses require cyclophilins for replication; these include human immunodeficiency virus, vesicular stomatitis virus, and hepatitis C virus. However, the molecular mechanisms leading to the suppression of viral replication differ for different viruses. This review describes the suppressive effects of CsA on coronavirus replication.
Keywords: cyclophilin; cyclosporin A; coronavirus; NF-AT
PDF Full-text Download PDF Full-Text [423 KB, uploaded 22 May 2013 11:18 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Tanaka, Y.; Sato, Y.; Sasaki, T. Suppression of Coronavirus Replication by Cyclophilin Inhibitors. Viruses 2013, 5, 1250-1260.

AMA Style

Tanaka Y, Sato Y, Sasaki T. Suppression of Coronavirus Replication by Cyclophilin Inhibitors. Viruses. 2013; 5(5):1250-1260.

Chicago/Turabian Style

Tanaka, Yoshikazu; Sato, Yuka; Sasaki, Takashi. 2013. "Suppression of Coronavirus Replication by Cyclophilin Inhibitors." Viruses 5, no. 5: 1250-1260.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert